Morgan Stanley’s Freeline Therapeutics Holdings plc American Depositary Shares FRLN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-85,514
| Closed | -$545K | – | 8078 |
|
|
2023
Q4 | $545K | Buy |
85,514
+43,080
| +102% | +$274K | ﹤0.01% | 5586 |
|
|
2023
Q3 | $182K | Buy |
42,434
+7,572
| +22% | +$32.6K | ﹤0.01% | 5628 |
|
|
2023
Q2 | $89.9K | Buy |
34,862
+22,228
| +176% | +$57.3K | ﹤0.01% | 6000 |
|
|
2023
Q1 | $86.2K | Sell |
12,634
-126
| -1% | -$860 | ﹤0.01% | 6073 |
|
|
2022
Q4 | $90.9K | Buy |
12,760
+1,217
| +11% | +$8.67K | ﹤0.01% | 6017 |
|
|
2022
Q3 | $121K | Sell |
11,543
-1,320
| -10% | -$13.8K | ﹤0.01% | 5986 |
|
|
2022
Q2 | $168K | Buy |
12,863
+548
| +4% | +$7.16K | ﹤0.01% | 5982 |
|
|
2022
Q1 | $207K | Buy |
12,315
+5,213
| +73% | +$87.6K | ﹤0.01% | 5908 |
|
|
2021
Q4 | $211K | Buy |
7,102
+4,346
| +158% | +$129K | ﹤0.01% | 6033 |
|
|
2021
Q3 | $141K | Buy |
2,756
+514
| +23% | +$26.3K | ﹤0.01% | 6186 |
|
|
2021
Q2 | $274K | Buy |
2,242
+754
| +51% | +$92.1K | ﹤0.01% | 5857 |
|
|
2021
Q1 | $275K | Sell |
1,488
-303
| -17% | -$56K | ﹤0.01% | 5477 |
|
|
2020
Q4 | $490K | Buy |
1,791
+911
| +104% | +$249K | ﹤0.01% | 5092 |
|
|
2020
Q3 | $206K | Buy |
+880
| New | +$206K | ﹤0.01% | 5103 |
|